FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2267930951> ?p ?o ?g. }

• W2267930951 endingPage "12" @default.
• W2267930951 startingPage "8" @default.
• W2267930951 abstract "PurposeTo identify the factors influencing topiramate pharmacokinetics (PK) in a large population of adult patients with epilepsy using population PK analysis.MethodsClinical data and blood samples were collected from 550 adult patients with epilepsy treated using topiramate. Nonlinear mixed effects modeling software (NONMEM, version 7.2) was used to fit the plasma concentration to a one-compartment PK model. Demographic and clinical variables tested as potential covariates were age, sex, body weight, height, serum creatinine, creatinine clearance (CLcr), total bilirubin, prothrombin time, albumin, aspartate transaminase (AST), alanine transaminase (ALT), daily dose (DOSE), and concomitant medications (phenytoin [PHT], clobazam, carbamazepine [CBZ], valproic acid, lamotrigine, levetiracetam, oxcarbazepine [OXC], pregabalin, clonazepam, and phenobarbital [PB]).ResultsThe final PK model was CL/F (L/h) = (1.16 + 1.36 × PHT + 1.01 × CBZ + 0.643 × OXC + 0.476 × PB) × (CLcr/90)0.310 × (DOSE/100)0.0929 (1 in patients co-medicated with each drug, 0 in otherwise) and V/F (L) = 109 × (WT/62). For a typical patient with CLcr of 90 mL/min and DOSE of 100 mg, co-medication with PHT, CBZ, OXC, and PB increased the CL/F to 2.52 (1.16 + 1.36) L/h, 2.17 (1.16 + 1.01) L/h, 1.803 (1.16 + 0.643) L/h, and 1.636 (1.16 + 0.476) L/h, respectively, which was 117, 87, 55, and 41% higher, respectively, than in patients without co-medication.ConclusionThe apparent clearance of topiramate increased with co-medication of PHT, CBZ, OXC, and PB. This population PK model can be applied for optimizing topiramate dosage regimens in actual clinical practice." @default.
• W2267930951 created "2016-06-24" @default.
• W2267930951 creator A5003269397 @default.
• W2267930951 creator A5006805755 @default.
• W2267930951 creator A5008732364 @default.
• W2267930951 creator A5011180204 @default.
• W2267930951 creator A5050885102 @default.
• W2267930951 creator A5064370332 @default.
• W2267930951 creator A5067571000 @default.
• W2267930951 creator A5078868975 @default.
• W2267930951 creator A5089200258 @default.
• W2267930951 creator A5091036340 @default.
• W2267930951 date "2016-04-01" @default.
• W2267930951 modified "2023-10-13" @default.
• W2267930951 title "Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis" @default.
• W2267930951 cites W1481636658 @default.
• W2267930951 cites W1967729348 @default.
• W2267930951 cites W1977421668 @default.
• W2267930951 cites W1983406399 @default.
• W2267930951 cites W2000830697 @default.
• W2267930951 cites W2012891482 @default.
• W2267930951 cites W2014084293 @default.
• W2267930951 cites W2026414192 @default.
• W2267930951 cites W2033585926 @default.
• W2267930951 cites W2035387023 @default.
• W2267930951 cites W2037292769 @default.
• W2267930951 cites W2055864845 @default.
• W2267930951 cites W2055875149 @default.
• W2267930951 cites W2064373853 @default.
• W2267930951 cites W2066185458 @default.
• W2267930951 cites W2074486762 @default.
• W2267930951 cites W2080379296 @default.
• W2267930951 cites W2080494081 @default.
• W2267930951 cites W2086867089 @default.
• W2267930951 cites W2094667091 @default.
• W2267930951 cites W2117837867 @default.
• W2267930951 cites W2132257746 @default.
• W2267930951 cites W2333132792 @default.
• W2267930951 doi "https://doi.org/10.1016/j.seizure.2016.02.002" @default.
• W2267930951 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26908152" @default.
• W2267930951 hasPublicationYear "2016" @default.
• W2267930951 type Work @default.
• W2267930951 sameAs 2267930951 @default.
• W2267930951 citedByCount "17" @default.
• W2267930951 countsByYear W22679309512017 @default.
• W2267930951 countsByYear W22679309512018 @default.
• W2267930951 countsByYear W22679309512019 @default.
• W2267930951 countsByYear W22679309512020 @default.
• W2267930951 countsByYear W22679309512021 @default.
• W2267930951 countsByYear W22679309512022 @default.
• W2267930951 countsByYear W22679309512023 @default.
• W2267930951 crossrefType "journal-article" @default.
• W2267930951 hasAuthorship W2267930951A5003269397 @default.
• W2267930951 hasAuthorship W2267930951A5006805755 @default.
• W2267930951 hasAuthorship W2267930951A5008732364 @default.
• W2267930951 hasAuthorship W2267930951A5011180204 @default.
• W2267930951 hasAuthorship W2267930951A5050885102 @default.
• W2267930951 hasAuthorship W2267930951A5064370332 @default.
• W2267930951 hasAuthorship W2267930951A5067571000 @default.
• W2267930951 hasAuthorship W2267930951A5078868975 @default.
• W2267930951 hasAuthorship W2267930951A5089200258 @default.
• W2267930951 hasAuthorship W2267930951A5091036340 @default.
• W2267930951 hasBestOaLocation W22679309511 @default.
• W2267930951 hasConcept C112705442 @default.
• W2267930951 hasConcept C118552586 @default.
• W2267930951 hasConcept C160160445 @default.
• W2267930951 hasConcept C181199279 @default.
• W2267930951 hasConcept C185592680 @default.
• W2267930951 hasConcept C2776239304 @default.
• W2267930951 hasConcept C2777332695 @default.
• W2267930951 hasConcept C2777683783 @default.
• W2267930951 hasConcept C2777992146 @default.
• W2267930951 hasConcept C2778186239 @default.
• W2267930951 hasConcept C2778337148 @default.
• W2267930951 hasConcept C2778802184 @default.
• W2267930951 hasConcept C2779253243 @default.
• W2267930951 hasConcept C2779426884 @default.
• W2267930951 hasConcept C2779679107 @default.
• W2267930951 hasConcept C2780272996 @default.
• W2267930951 hasConcept C2781176495 @default.
• W2267930951 hasConcept C2908647359 @default.
• W2267930951 hasConcept C3020755252 @default.
• W2267930951 hasConcept C55493867 @default.
• W2267930951 hasConcept C71924100 @default.
• W2267930951 hasConcept C98274493 @default.
• W2267930951 hasConcept C99454951 @default.
• W2267930951 hasConceptScore W2267930951C112705442 @default.
• W2267930951 hasConceptScore W2267930951C118552586 @default.
• W2267930951 hasConceptScore W2267930951C160160445 @default.
• W2267930951 hasConceptScore W2267930951C181199279 @default.
• W2267930951 hasConceptScore W2267930951C185592680 @default.
• W2267930951 hasConceptScore W2267930951C2776239304 @default.
• W2267930951 hasConceptScore W2267930951C2777332695 @default.
• W2267930951 hasConceptScore W2267930951C2777683783 @default.
• W2267930951 hasConceptScore W2267930951C2777992146 @default.
• W2267930951 hasConceptScore W2267930951C2778186239 @default.
• W2267930951 hasConceptScore W2267930951C2778337148 @default.
• W2267930951 hasConceptScore W2267930951C2778802184 @default.

• next